205 related articles for article (PubMed ID: 38242896)
1. A transcriptomic analysis in mice following a single dose of ibogaine identifies new potential therapeutic targets.
Biosca-Brull J; Ona G; Alarcón-Franco L; Colomina MT
Transl Psychiatry; 2024 Jan; 14(1):41. PubMed ID: 38242896
[TBL] [Abstract][Full Text] [Related]
2. Main targets of ibogaine and noribogaine associated with its putative anti-addictive effects: A mechanistic overview.
Ona G; Reverte I; Rossi GN; Dos Santos RG; Hallak JE; Colomina MT; Bouso JC
J Psychopharmacol; 2023 Dec; 37(12):1190-1200. PubMed ID: 37937505
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine and neurochemical effects of acute ibogaine administration: a time course evaluation.
Ali SF; Newport GD; Slikker W; Rothman RB; Baumann MH
Brain Res; 1996 Oct; 737(1-2):215-20. PubMed ID: 8930368
[TBL] [Abstract][Full Text] [Related]
4. Application of electrophysiological method to study interactions between ibogaine and cocaine.
Binienda Z; Beaudoin MA; Thorn BT; Sadovova N; Skinner RD; Slikker W; Ali SF
Ann N Y Acad Sci; 2000 Sep; 914():387-93. PubMed ID: 11085337
[TBL] [Abstract][Full Text] [Related]
5. Ibogaine attenuation of morphine withdrawal in mice: role of glutamate N-methyl-D-aspartate receptors.
Leal MB; Michelin K; Souza DO; Elisabetsky E
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):781-5. PubMed ID: 12921910
[TBL] [Abstract][Full Text] [Related]
6. Alteration of electroencephalogram and monoamine concentrations in rat brain following ibogaine treatment.
Binienda Z; Beaudoin MA; Thorn BT; Prapurna DR; Johnson JR; Fogle CM; Slikker W; Ali SF
Ann N Y Acad Sci; 1998 May; 844():265-73. PubMed ID: 9668684
[TBL] [Abstract][Full Text] [Related]
7. Neurochemical and neuroendocrine effects of ibogaine in rats: comparison to MK-801.
Baumann MH; Rothman RB; Ali SF
Ann N Y Acad Sci; 1998 May; 844():252-64. PubMed ID: 9668683
[TBL] [Abstract][Full Text] [Related]
8. Noribogaine (12-hydroxyibogamine): a biologically active metabolite of the antiaddictive drug ibogaine.
Baumann MH; Pablo JP; Ali SF; Rothman RB; Mash DC
Ann N Y Acad Sci; 2000 Sep; 914():354-68. PubMed ID: 11085335
[TBL] [Abstract][Full Text] [Related]
9. Acute ibogaine injection induces expression of the immediate early genes, egr-1 and c-fos, in mouse brain.
Ali SF; Thiriet N; Zwiller J
Brain Res Mol Brain Res; 1999 Dec; 74(1-2):237-41. PubMed ID: 10640697
[TBL] [Abstract][Full Text] [Related]
10. Sex differences in ibogaine antagonism of morphine-induced locomotor activity and in ibogaine brain levels and metabolism.
Pearl SM; Hough LB; Boyd DL; Glick SD
Pharmacol Biochem Behav; 1997 Aug; 57(4):809-15. PubMed ID: 9259010
[TBL] [Abstract][Full Text] [Related]
11. [Ibogaine--the substance for treatment of toxicomania. Neurochemical and pharmacological action].
Kazlauskas S; Kontrimaviciūte V; Sveikata A
Medicina (Kaunas); 2004; 40(3):216-9. PubMed ID: 15064541
[TBL] [Abstract][Full Text] [Related]
12. The effects of ibogaine on dopamine and serotonin transport in rat brain synaptosomes.
Wells GB; Lopez MC; Tanaka JC
Brain Res Bull; 1999 Apr; 48(6):641-7. PubMed ID: 10386845
[TBL] [Abstract][Full Text] [Related]
13. Ibogaine signals addiction genes and methamphetamine alteration of long-term potentiation.
Onaivi ES; Ali SF; Chirwa SS; Zwiller J; Thiriet N; Akinshola BE; Ishiguro H
Ann N Y Acad Sci; 2002 Jun; 965():28-46. PubMed ID: 12105083
[TBL] [Abstract][Full Text] [Related]
14. A Single Administration of the Atypical Psychedelic Ibogaine or Its Metabolite Noribogaine Induces an Antidepressant-Like Effect in Rats.
Rodrı Guez P; Urbanavicius J; Prieto JP; Fabius S; Reyes AL; Havel V; Sames D; Scorza C; Carrera I
ACS Chem Neurosci; 2020 Jun; 11(11):1661-1672. PubMed ID: 32330007
[TBL] [Abstract][Full Text] [Related]
15. A dose-response study of ibogaine-induced neuropathology in the rat cerebellum.
Xu Z; Chang LW; Slikker W; Ali SF; Rountree RL; Scallet AC
Toxicol Sci; 2000 Sep; 57(1):95-101. PubMed ID: 10966515
[TBL] [Abstract][Full Text] [Related]
16. Ibogaine acts at the nicotinic acetylcholine receptor to inhibit catecholamine release.
Mah SJ; Tang Y; Liauw PE; Nagel JE; Schneider AS
Brain Res; 1998 Jun; 797(1):173-80. PubMed ID: 9630615
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of ibogaine on local cerebral glucose utilization in drug-naive and morphine-dependent rats.
Levant B; Pazdernik TL
Brain Res; 2004 Apr; 1003(1-2):159-67. PubMed ID: 15019575
[TBL] [Abstract][Full Text] [Related]
18. Alteration in Electroencephalogram and Monoamine Concentrations in Rat Brain following Ibogaine Treatment.
Binienda Z; Beaudoin MA; Thorn BT; Prapurna DR; Johnson JR; Fogle CM; Slikker W; Ali SF
Ann N Y Acad Sci; 1998 May; 844(1):265-273. PubMed ID: 29090814
[TBL] [Abstract][Full Text] [Related]
19. Effects of ibogaine and noribogaine on phosphoinositide hydrolysis.
Rabin RA; Winter JC
Brain Res; 1996 Aug; 731(1-2):226-9. PubMed ID: 8883876
[TBL] [Abstract][Full Text] [Related]
20. Examination of the Phenomenology of the Ibogaine Treatment Experience: Role of Altered States of Consciousness and Psychedelic Experiences.
Heink A; Katsikas S; Lange-Altman T
J Psychoactive Drugs; 2017; 49(3):201-208. PubMed ID: 28266890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
